Evidence map›Paper›PMID 41551651›Full record

ArticleFrontiers in microbiology2025

Isolation and characterization of novel lytic bacteriophages against (fluoro)quinolone-resistant

Yuran Elías Calancha-Padrón, Dayana Perez-Condori, Marcelo Fernando Gutierrez-Valverde, Daniel Martin Salas-Veizaga, Karin Hjort, María Teresa Alvarez-Aliaga

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuran Elías Calancha-PadrónÁrea de Bioquímica Molecular, Instituto de Investigaciones Fármaco Bioquímicas, Universidad Mayor de San Andrés, La Paz, Bolivia.
Dayana Perez-CondoriÁrea de Bioquímica Molecular, Instituto de Investigaciones Fármaco Bioquímicas, Universidad Mayor de San Andrés, La Paz, Bolivia.
Marcelo Fernando Gutierrez-ValverdeÁrea de Bioquímica Molecular, Instituto de Investigaciones Fármaco Bioquímicas, Universidad Mayor de San Andrés, La Paz, Bolivia.
Daniel Martin Salas-VeizagaÁrea de Bioquímica Molecular, Instituto de Investigaciones Fármaco Bioquímicas, Universidad Mayor de San Andrés, La Paz, Bolivia.
Karin HjortDepartment of Medical Biochemistry and Microbiology, Biomedicinskt Centrum, Uppsala University, Uppsala, Sweden.
María Teresa Alvarez-AliagaÁrea de Bioquímica Molecular, Instituto de Investigaciones Fármaco Bioquímicas, Universidad Mayor de San Andrés, La Paz, Bolivia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) has become a global public health concern, particularly in developing countries where antibiotics are often overused and misused. In Bolivia, the indiscriminate use of antibiotics, including (fluoro-)quinolones, has led to the proliferation of multidrug-resistant (MDR)

Indexed as

antimicrobial resistancebacteriophagesCampylobacter spp.(fluoro-)quinolone resistancelytic activity

Identifiers

PMID41551651
PMCPMC12808351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.